Innate and Adaptive Immunity in Calcific Aortic Valve Disease
Open accessThe DOI matches its Crossref record; 103 of the 104 references it cites were found in a registry or an index.
Abstract
Calcific aortic valve disease (CAVD) is the most common heart valve disorder. CAVD is a chronic process characterized by a pathologic mineralization of valve leaflets. Ectopic mineralization of the aortic valve involves complex relationships with immunity. Studies have highlighted that both innate and adaptive immunity play a role in the development of CAVD. In this regard, accumulating evidence indicates that fibrocalcific remodelling of the aortic valve is associated with activation of the NF-κ B pathway. The expression of TNF-α and IL-6 is increased in human mineralized aortic valves and promotes an osteogenic program as well as the mineralization of valve interstitial cells (VICs), the main cellular component of the aortic valve. Different factors, including oxidized lipid species, activate the innate immune response through the Toll-like receptors. Moreover, VICs express 5-lipoxygenase and therefore produce leukotrienes, which may amplify the inflammatory response in the aortic valve. More recently, studies have emphasized that an adaptive immune response is triggered during CAVD. Herein, we are reviewing the link between the immune response and the development of CAVD and we have tried, whenever possible, to keep a translational approach.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.
Simonet, W. S., Lacey, D. L., Dunstan, C. R., Kelley, M., Chang, M.-S., Lüthy, R., Nguyen, H. Q., Wooden, S., Bennett, L., Boone, T., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80209-3 · Cited by 5,130
A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells
Black, R. A., Rauch, C. T., Kozlosky, C. J., Peschon, J. J., Slack, J. L., Wolfson, M. F., Castner, B. J., Stocking, K. L., Reddy, P., Srinivasan, S., et al. (1997) · Nature · doi:10.1038/385729a0 · Cited by 3,149 · cited 1×
“By using a wholegenome transcriptomic approach El Husseini et al. identified that, among the family of cytokines that signal through gp130, IL-6 is highly expressed in mineralized aortic valves [23].”
MethodOsteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification.
Bucay, N., Sarosi, I., Dunstan, C. R., Morony, S., Tarpley, J., Capparelli, C., Scully, S., Tan, H. L., Xu, W., Lacey, D. L., et al. (1998) · Genes & Development · doi:10.1101/gad.12.9.1260 · Cited by 2,483
The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation
Hsu, H., Xiong, J., & Goeddel, D. V. (1995) · Cell · doi:10.1016/0092-8674(95)90070-5 · Cited by 2,012
Hsu, H., Shu, H.-B., Pan, M.-G., & Goeddel, D. V. (1996) · Cell · doi:10.1016/s0092-8674(00)80984-8 · Cited by 1,998
Mutations in NOTCH1 cause aortic valve disease
Garg, V., Muth, A. N., Ransom, J. F., Schluterman, M. K., Barnes, R., King, I. N., Grossfeld, P. D., & Srivastava, D. (2005) · Nature · doi:10.1038/nature03940 · Cited by 1,509
Otto, C. M., Kuusisto, J., Reichenbach, D. D., Gown, A. M., & O'Brien, K. D. (1994) · Circulation · doi:10.1161/01.cir.90.2.844 · Cited by 1,315
RANKL–RANK signaling in osteoclastogenesis and bone disease
Wada, T., Nakashima, T., Hiroshi, N., & Penninger, J. M. (2006) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2005.11.007 · Cited by 1,212
Zhong, H., Voll, R. E., & Ghosh, S. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80066-0 · Cited by 1,210
Beg, A. A., Finco, T. S., Nantermet, P. V., & Baldwin, A. S. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.6.3301 · Cited by 1,027
Cited by
Items 101–139 of 139
Baddour, T., Ninh, V. K., Gorashi, R. M., Peña, R., King, K. R., & Aguado, B. A. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.08.20.671175 · Cited by 2
Gong, X., Wang, M., Wang, L., Huang, S., Huang, B., Chen, T., Xia, L., Wei, W., Zhang, Q., Hu, J., et al. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1482313 · Cited by 1
Кальциноз клапанів серця: сучасний погляд на проблему та перспективи досліджень (огляд літератури)
Kryvenko, V. I., Качан, И. С., Fedorova, O. P., Kolesnyk, M. Y., Nepryadkina, I. V., Pachomova, S. P., Borodavko, O. I., & Borota, D. S. (2021) · The Practitioner · Cited by 1
Mechanisms of calcification in the aortic wall and aortic valve
Passos, L. S. A., BECKER-GREENE, D. R., & Aïkawa, E. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91391-1.00021-2 · Cited by 1
Xiong, T., Chen, Y., Shen, H., Zhang, T.-C., Pu, L., Fan, Y., Fan, W.-C., Zhang, Y.-Y., & Li, Y.-X. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.913776 · Cited by 2
Role of microparticles in aortic valve thrombogenecity
Hmadeh, S. (2022) · theses.fr (ABES) · doi:10.70675/10f713f4z0a75z4284z94b2z09ccf288aab9 · Cited by 1
Sumpf, B. I. (2018) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-10174
Molecular Mechanisms of Aortic Valve Pathology
Mkannez, G., Argaud, D., Boulanger, M., & Mathieu, P. (2019) · Springer eBooks · doi:10.1007/978-3-7091-4874-7_5
Self-citationSchneider, M. (2019) · edoc Publication server (Humboldt University of Berlin) · doi:10.18452/19810
Effects of interferons and their interactions with other ligands in human aortic valve cells
Izquierdo, I. P. (2019) · UVaDOC UVaDOC University of Valladolid Documentary Repository (University of Valladolid) · doi:10.35376/10324/39470
Cellular and molecular mechanisms of human aortic valve calcification
Bogdanova, M. (2019) · NVA (Nasjonalt vitenarkiv)
Bon-Baret, V., Chignon, A., Boulanger, M., & Mathieu, P. (2020) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.120.314733
Self-citationValve Calcification (Aortic and Mitral)
Kho, J., & Petrou, M. (2021) · Springer eBooks · doi:10.1007/978-3-030-81515-8_4
Kovanen, P. T., & Bäck, M. (2017) · Oxford University Press eBooks · doi:10.1093/med/9780198755777.003.0015
The Effect of Immunomodulatory Drugs on Aortic Stenosis: A Mendelian Randomisation Analysis
Ciofani, J. L., Han, D., Nazarzadeh, M., Allahwala, U. K., Maria, G. D., BANNING, A. P., Bhindi, R., & Rahimi, K. (2023) · Heart Lung and Circulation · doi:10.1016/j.hlc.2023.06.447
de Oliveira, J. L. R. (2022) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.98.2022.tde-13072023-201032
Richard, A. (2023) · theses.fr (ABES) · doi:10.70675/827eccebz236cz4d59zae22z6d9371f39198
Yu, Z., Men, S., Daitoku, K., Imaizumi, T., Minakawa, M., & Seya, K. (2025) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2025.07.004
Li, K., Luo, Y., Huang, H., & Yan-ting, C. (2025) · Angiology · doi:10.1177/00033197251376086
Sánchez‐Bayuela, T., Peral-Rodrigo, M., López, J., Gómez, C., Pérez-Riesgo, E., López‐Andrés, N., Fernández, N., Román, J. A. S., Crespo, M. S., & García‐Rodríguez, C. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.12.693904
Mecanismos de remodelado y calcificación cardiovascular: papel del receptor nuclear NOR-1 y la LOX
Ballester‐Servera, C. (2023) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
Pérez, D. L. M. (2024) · UVaDOC UVaDOC University of Valladolid Documentary Repository (University of Valladolid)
Évolution du fardeau de la sténose aortique dans la province de Québec entre 2000 et 2015
Frieden, P. (2021) · Corpus Université Laval (Université Laval)
Chen, Y.-J., Chen, H.-P., Zhang, C. Y., Rong, X., Li, K.-L., Xiao, F., & Wang, R.-X. (2026) · Reviews in Cardiovascular Medicine · doi:10.31083/rcm42804
Importance des processus angiogéniques au cours des pathologies valvulaires
Gendron, N. (2018) · theses.fr (ABES) · doi:10.70675/1b7507f9z4714z433bz9a6cz7c689b7f5148
Relations between aortic valve calcification and telomere lenght dynamics
Saraieva, I. (2020) · theses.fr (ABES) · doi:10.70675/c98af202z0365z444bz8ee1z337555d97246
Implication du canal cationique TRPM4 dans le remodelage radio-induit de la valve aortique
Bangando, H. M. (2022) · theses.fr (ABES) · doi:10.70675/3ae45780z740az4ee9zbf19zb0be0024bdb2
Song, R., Jin, W., Zheng, H., He, S., Li, H., Zhong, J., Xian, H., Hu, Y., & Zhang, M. (2026) · Eurasian Journal of Medicine and Oncology · doi:10.36922/ejmo025360375
Sánchez‐Bayuela, T., Peral-Rodrigo, M., López, J. S., Gómez, C., Pérez-Riesgo, E., Cacace, J., López‐Andrés, N., Fernández, N., Víctor, V. M., Román, J. A. S., et al. (2026) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00974.2025
Sex differences in innate immune phenotype and valvular remodelling in aortic stenosis
van Doorn, E. P. M., Broeders, W., van Broekhoven, A., Cetinyurek‐Yavuz, A., Zegers, E. S., Niessen, H. W. M., Netea, M. G., van Royen, N., den Ruijter, H. M., Riksen, N. P., et al. (2026) · European Heart Journal - Valvular and Structural Heart Disease · doi:10.1093/ehjvshd/xwag055
Современный взгляд на роль цитокинов в иммунопатогенезе коронарного кальциноза: обзор литературы
Шлык, И. Ф., Закурская, В. Я., Беседина, Д. Ю., Харитонова, М. В., & Моргунов, М. Н. (2026) · Кардиология в Беларуси · doi:10.34883/pi.2026.18.5.011
Zhang, Q., Ye, J., Yang, G., Yang, L., Chen, Z., Yang, K., Sun, J. T., & Liu, Y. (2023) · doi:10.3389/fcvm.2022.1050310.s003
Xiong, T., Chen, Y., Han, S., Zhang, T.-C., Pu, L., Fan, Y.-X., Fan, W.-C., Zhang, Y.-Y., & Li, Y.-X. (2022) · doi:10.3389/fcvm.2022.913776.s004
Metadata
- Authors
- Mathieu, P., Bouchareb, R., & Boulanger, M.-C.
- Affiliations
- Institut universitaire de cardiologie et de pneumologie de Québec (CA)
- Corresponding author
- Mathieu, Patrick
- Venue
- Journal of Immunology Research
- Publisher
- Wiley
- Published
- 2015
- Volume
- 2015
- Pages
- 1-11
- ISSN
- 2314-7156 (ISSN-L)
- 2314-8861
- PMC
- PMC4433691
- OpenAlex
- W1963647443
- Cited by
- 121
- References
- 104
- Citations by year
- 2026: 7 · 2025: 14 · 2024: 8 · 2023: 12 · 2022: 18 · 2021: 15 · 2020: 12 · 2019: 10 · 2018: 7 · 2017: 10 · 2016: 7 · 2015: 1
- FWCI
- 1.43
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Journal of Immunology Research (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- Havering Sixth Form College (MOP245048, MOP114893)
- Canadian Institutes of Health Research (MOP245048, MOP114893)
- Quebec Heart and Lung Institute (MOP245048, MOP114893)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Valve Diseases and Treatments
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Keywords
- calcific aortic valve disease, innate immunity, adaptive immunity, valvular interstitial cells, NF-κB signaling, TNF-α, interleukin-6, osteogenic differentiation, Toll-like receptors, oxidized lipids, 5-lipoxygenase, leukotrienes, inflammation
- MeSH terms
- Bicuspid Aortic Valve Disease, Animals, Aortic Valve, Aortic Valve Stenosis, Calcinosis, Heart Defects, Congenital, Heart Valve Diseases, Humans, Immunity, Innate, Tumor Necrosis Factor-alpha, Interleukin-6, NF-kappa B, Adaptive Immunity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.